Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Nov;116(11):2837-42.
doi: 10.1172/JCI29999.

Drug discovery in jeopardy

Pedro Cuatrecasas  1
Affiliations

Drug discovery in jeopardy

Pedro Cuatrecasas. J Clin Invest. 2006 Nov.

Abstract

Despite striking advances in the biomedical sciences, the flow of new drugs has slowed to a trickle, impairing therapeutic advances as well as the commercial success of drug companies. Reduced productivity in the drug industry is caused mainly by corporate policies that discourage innovation. This is compounded by various consequences of mega-mergers, the obsession for blockbuster drugs, the shift of control of research from scientists to marketers, the need for fast sales growth, and the discontinuation of development compounds for nontechnical reasons. Lessons from the past indicate that these problems can be overcome, and herein, new and improved directions for drug discovery are suggested.

PubMed Disclaimer

References

    1. Booth B., Zemmel R. Prospects for productivity. Nat. Rev. Drug Discov. . 2004;3:451–456. - PubMed
    1. Frantz S. FDA publishes analysis of the pipeline problem. Nat. Rev. Drug Discov. . 2004;3:279. - PubMed
    1. Mervis J. Productivity counts — but the definition is key. Science. 2005;309:726–727. - PubMed
    1. Wood A.J.J. A proposal for radical changes in the drug-approval process. N. Engl. J. Med. . 2006;355:618–623. - PubMed
    1. Kennedy D. FDA centennial [editorial]. . Science. . 2006;312:19. - PubMed

Publication types